GUAIFENESIN- guaifenesin tablet 
Apace Packaging, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Guaifenesin Tablets USP, 200 mg (Product contract packaged by Apace Packaging, LLC)

Drug Facts

Active Ingredient

(in each immediate-release tablet)

Guaifenesin USP, 200 mg

Purpose

Expectorant

Uses

Helps loosen phlegm(mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

WARNINGS

Ask a doctor before use if you have

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm(mucus)

stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. This could be signs of a serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • do not take more than 6 doses in any 24-hour period
  • this product is not intended for use in children under 12 years of age
    adults and children 12 years and over1 to 2 tablets every 4 hours
    Children under 12 yearsDo not use

Other Information

  • store at 15-30 °C (59-86 °F)
  • you may report serious side effects to: AvKARE, Inc. at 1 (855) 361-3993 

Inactive Ingredients

Colloidal silicon dioxide, FD&C red #40(Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid

Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Mfg. Rev. 04/15                 AV 09/16 (P)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50268-382-15
Guaifenesin Tablets USP
200mg
EXPECTORANT
For Ages 12 and Over
50 Tablets (5 x 10) Unit Dose
5026838215

NDC 50268-382-15
Guaifenesin Tablets USP
200mg
EXPECTORANT
For Ages 12 and Over
50 Tablets (5 x 10) Unit Dose
5026838215

Drug Facts

Active ingredient                                       Purpose
(in each immediate-release tablet)

Guaifenesin USP, 200 mg ...................... Expectorant

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Drug Facts (continued)

Warnings
Ask a doctor before use if you have

• persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema.
• cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if cough last more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
• do not take more than 6 doses in any 24-hour period
• this product is not intended for use in children under 12 years of age

adults and children 12 years and over                1 to 2 tablets every 4 hours

children under 12 years                                      do not use

Drug Facts (continued)

Other information
• store at 15° to 30°C (59° to 86°F).
You may report serious side effects to: AvKARE, Inc. at 1 (855) 361-3993

Inactive ingredients
colloidal silicon dioxide, FD&C red #40 (Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid.

Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Mfg. Rev. 04/15 AV 09/16 (P)

label 1
label 2
label 3
GUAIFENESIN 
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:15338-769(NDC:0603-4890)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POVIDONE (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorredScorescore with uneven pieces
ShapeROUNDSize10mm
FlavorImprint Code AP;151
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:15338-769-0550 in 1 BOX, UNIT-DOSE10/04/2016
1NDC:15338-769-111 in 1 BLISTER PACK; Type 0: Not a Combination Product
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34110/04/2016
Labeler - Apace Packaging, LLC (361961142)
Establishment
NameAddressID/FEIBusiness Operations
Advance Pharmaceutical Inc078301063manufacture(15338-769)
Establishment
NameAddressID/FEIBusiness Operations
Apace Packaging, LLC361961142repack(15338-769) , label(15338-769)

Revised: 11/2018
 
Apace Packaging, LLC